ABIN2846124
antibody from antibodies-online
Targeting: BCL2A1
ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2846124 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-B Cell Leukemia/lymphoma 2 Related Protein A1a (BCL2A1A) (AA 30-65), (BH3 Domain) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 30-65, BH3 Domain
- Antibody clone number
- RB1251
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.
Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma.
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens.
The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.
Deng X, Gao F, May WS
Blood 2009 Jan 8;113(2):422-8
Blood 2009 Jan 8;113(2):422-8
Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma.
Gollob JA, Sciambi CJ, Huang Z, Dressman HK
Cancer research 2005 Oct 1;65(19):8869-77
Cancer research 2005 Oct 1;65(19):8869-77
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens.
Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H, Tsujimura K, Yazaki M, Naoe T, Morishima Y, Kodera Y, Kuzushima K, Takahashi T
The Journal of experimental medicine 2003 Jun 2;197(11):1489-500
The Journal of experimental medicine 2003 Jun 2;197(11):1489-500
The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.
Akari H, Bour S, Kao S, Adachi A, Strebel K
The Journal of experimental medicine 2001 Nov 5;194(9):1299-311
The Journal of experimental medicine 2001 Nov 5;194(9):1299-311
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC